Rentokil Initial - Public Comps and Valuation Multiples

Rentokil Initial Overview

About Rentokil Initial

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

Founded

2005

HQ

Employees

65.6K+

Website

rentokil-initial.com

Sectors

Environmental & Facilities Services
Service Providers
ClimateTech

Financials

LTM Revenue $5.2B

LTM EBITDA $1.1B

EV

$17.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Rentokil Initial Financials

As of August 2025, Rentokil Initial reported last 12-month revenue of $5.2B and EBITDA of $1.1B.

In the same period, Rentokil Initial generated $4.1B in LTM gross profit and $492M in net income.

See Rentokil Initial valuation multiples based on analyst estimates

Rentokil Initial P&L

In the most recent fiscal year, Rentokil Initial reported revenue of $9.2B and EBITDA of $1.9B.

Rentokil Initial expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Rentokil Initial valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$5.2B	XXX	$9.2B	XXX	XXX	XXX
Gross Profit	$4.1B	XXX	$7.7B	XXX	XXX	XXX
Gross Margin	78%	XXX	84%	XXX	XXX	XXX
EBITDA	$1.1B	XXX	$1.9B	XXX	XXX	XXX
EBITDA Margin	21%	XXX	20%	XXX	XXX	XXX
EBIT	$781M	XXX	$1.0B	XXX	XXX	XXX
EBIT Margin	15%	XXX	11%	XXX	XXX	XXX
Net Profit	$492M	XXX	$520M	XXX	XXX	XXX
Net Margin	9%	XXX	6%	XXX	XXX	XXX
Net Debt	XXX	XXX	$4.7B	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Rentokil Initial including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $5.2B. EBITDA for the last twelve months was $1.1B. In the most recent fiscal year, Rentokil Initial achieved $9.2B in revenue and $1.9B in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$5.2B	Analyst estimates available to subscribers	$9.2B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$4.1B	Analyst estimates available to subscribers	$7.7B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	78.3% gross margin	Analyst estimates available to subscribers	83.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$1.1B	Analyst estimates available to subscribers	$1.9B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	21.0% EBITDA margin	Analyst estimates available to subscribers	20.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$781M	Analyst estimates available to subscribers	$1.0B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	14.9% EBIT margin	Analyst estimates available to subscribers	11.1% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$492M	Analyst estimates available to subscribers	$520M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	9.4% net profit margin	Analyst estimates available to subscribers	5.6% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$4.7B	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Rentokil Initial

This financial data table provides comprehensive performance metrics for Rentokil Initial, a company based in United Kingdom of Great Britain and Northern Ireland. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Rentokil Initial generated $5.2B in revenue over the last twelve months.
The company achieved $1.1B in EBITDA over the last twelve months.
Gross profit for the last twelve months was $4.1B.
Net income over the last twelve months reached $492M.

Fiscal Year Performance

In the most recent fiscal year, Rentokil Initial reported $9.2B in total revenue.
Fiscal year EBITDA was $1.9B.
The company maintained a gross profit margin of 83.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was 20.3%.
Net profit margin reached 5.6% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Rentokil Initial. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Rentokil Initial Stock Performance

Rentokil Initial has current market cap of GBP 9.4B (or $12.7B), and EV of GBP 12.6B (or $17.0B).

Market Cap Evolution

Rentokil Initial Stock Data

As of September 12, 2025, Rentokil Initial's stock price is GBP 4 (or $5).

See Rentokil Initial trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$17.0B	$12.7B	XXX	XXX	XXX	XXX	$0.27

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Rentokil Initial Valuation Multiples

Rentokil Initial's trades at 1.8x EV/Revenue multiple, and 9.1x EV/EBITDA.

See valuation multiples for Rentokil Initial and 15K+ public comps

Rentokil Initial Financial Valuation Multiples

As of September 12, 2025, Rentokil Initial has market cap of $12.7B and EV of $17.0B.

Equity research analysts estimate Rentokil Initial's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Rentokil Initial has a P/E ratio of 19.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$12.7B	XXX	$12.7B	XXX	XXX	XXX
EV (current)	$17.0B	XXX	$17.0B	XXX	XXX	XXX
EV/Revenue	2.4x	XXX	1.8x	XXX	XXX	XXX
EV/EBITDA	11.5x	XXX	9.1x	XXX	XXX	XXX
EV/EBIT	16.1x	XXX	16.6x	XXX	XXX	XXX
EV/Gross Profit	3.1x	XXX	n/a	XXX	XXX	XXX
P/E	19.1x	XXX	24.4x	XXX	XXX	XXX
EV/FCF	34.1x	XXX	21.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Rentokil Initial Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Rentokil Initial Margins & Growth Rates

Rentokil Initial's last 12 month revenue growth is 1%

Rentokil Initial's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Rentokil Initial's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Rentokil Initial's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Rentokil Initial and other 15K+ public comps

Rentokil Initial Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	1%	XXX	-12%	XXX	XXX	XXX
EBITDA Margin	21%	XXX	20%	XXX	XXX	XXX
EBITDA Growth	1%	XXX	-15%	XXX	XXX	XXX
Rule of 40	22%	XXX	21%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	23%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	73%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial